MLS on the verge of breaking above that 31p high of April 2002. This was the item that triggered the current breakout last week:

LONDON (AFX) - Medical Solutions PLC, the cancer and pathology services
group, said The Doctors Laboratory, the leading provider of private cervical
screening in the UK, has stated that they are adopting Medical Solutions'
SurePath for their LBC screening.
The SurePath system will be supplied by Medical Solutions in the UK under
licence from TriPath Imaging Inc.
Medical Solutions chief executive Charles Green said the group now awaits
the NICE (the National Institute of Clinical Excellence) report issuing their
final guidance to the NHS, after their preliminary report recommended the use of
liquid based cytology within the NHS. This report is expected in September.
newsdesk@afxnews.com
slm/

See impressive bb comment here since then and on various BBs.

Interims due mid-Sept.
Ahead of a long weekend there might yet be some profit-taking, but with results and statements to come within the next 2-3 weeks I would guess most who are planning to do so will reduce rather than exit, and the effect will be perhaps be outweighed by new buyers waking up to what's happening.

MLS don't have the field to themselves with the nhs - there are still other contenders in the running. But it's looking hopeful in my opinion.

Company website

External Shareholders at 21 Aug 03:
89.15m 2p Ords - Edinburgh Fund Mgrs PLC 6.32%, INVESCO Asset Mgmt Ltd 5.78%, Prudential PLC 5.61%, Cantor Fitzgerald Europe 5.34%, Texas Group PLC 4.12%, Singer & Friedlander Inv 3.45%, Other Dirs 1.65%.

jzl

rodspotty

Thank You.

Disposal

RNS Number:3321J
Medical Solutions PLC
22 September 2006




Medical Solutions plc
(the "Company" or "Medical Solutions")

Proposed disposal of the Dubai based business of the Company

Medical Solutions, the provider of pathology and cytology services and products
to the healthcare and pharmaceuticals sectors, today announces that it has
entered into conditional agreements to sell 100% of the issued share capital in
Medical Solutions FZ LLC ("Dubai MedSol") its Dubai based pathology business for
an anticipated gross consideration of #16.4 million before expenses.

Summary of the transaction

*83.4% of the issued share capital in Dubai MedSol will be sold to
two Middle Eastern investment entities, Global Fund Company (Bahrain) EC and
Global Investment House KSCC based in Kuwait, for a consideration of #12.9
million payable in cash.

*The Consideration is also subject to adjustments in respect of cash
and working capital balances in Dubai MedSol as at 31 August 2006 which is
expected to result in an additional payment of #1.0 million to the Company.

*The remaining 16.6% of the issued share capital in Dubai MedSol will
be transferred to International Healthcare Holdings Limited ("IHHL"), a company
controlled by Mr Sunny Varkey in full and final settlement of a debt of #2.5
million owing by Medical Solutions plc to Welcare Hospital LLC and Welcare World
Health Systems Limited, both companies controlled by Mr Sunny Varkey.

*Cash consideration is therefore expected to be approximately #13.9
million before deduction of estimated expenses of approximately #1.0 million.

*The Directors intend to use the expected net cash proceeds of #12.9
million to invest in the Company's UK pathology and cytology businesses. The
Directors also intend to conduct a full strategic review before the end of the
year.

Neil Johnston, Chief Executive of Medical Solutions plc said,

"In December 2004 the Board outlined a clear strategy for the future development
of Medical Solutions that would set the company on the path to profitability.
The initial benefits of this strategy were highlighted by the Group announcing a
maiden profit in its interim results for the six months ended 30 June 2006. The
sale of the Dubai businesses is the latest stage in the process of ensuring the
long term success of the Company and the funds generated will enable significant
investment in the UK pathology and cytology businesses that will form the main
focus of operations going forward."

Enquiries:
Medical Solutions plc
Neil Johnston, Chief Executive Officer 0115 973 9010
Nick Ash, Chief Financial Officer 0115 973 9010

Bell Pottinger Corporate & Financial
Geoff Callow/Chris Hamilton 020 7861 3232

Nomura Code Securities Limited
Richard Potts 020 7776 1200

Details of the proposed sale of Dubai MedSol

This is NOT a ramp, but to demonstrate just how depressed the medical sector is, MLS will soon have 15m in cash, when the Dubai disposal is complete(see todays ''A''), the market cap at the present share price is 12.5m, which values their UK diagnostics business at sub zero ????? DYOR

Rodders

From FT.com

Medical Solutions rose 6.4 per cent to 6.1p after announcing the sale of its Dubai labs business for 12.9m, or 500,000 more than its curernt market value. The company will use the proceeds to invest in its UK pathology and cytology business, which Nomura Code Securities reckons is worth 12m.

Rodders

MLS on the rise this morning, little or no trades, still trading at a discount to cash with the business thrown in for free (valued by Nomura in a recent BUY note at 12m). DYOR

Rodders

From FT today

Here is the link.

http://www.ft.com/cms/s/92381f54-54d6-11db-901f-0000779e2340.html

"SMALL-CAPS: MBO TALK LIFTS MEDICAL SOLUTIONS
By Robert Orr and Neil Hume

Published: October 6 2006 03:00 | Last updated: October 6 2006 03:00

*Talk of a management buy-out approach sent Medical Solutions 12.5 per cent higher to 6p. Shares in the healthcare technology group have failed to break through 10p for the best part of two years. It recently sold its Dubai pathology business for 12.9m, roughly equal to its present market value."


Rodders

On the up today and well bid, EVO's seem keen. DYOR

Rodders

On the up again today, with EVO's again aggresively on the bid, share price still below cash in the bank. EGM tomorrow to rubber stamp the sale of their Dubai opps. DYOR

Rodders